| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.933599 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240312152932 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 240207e201903##onca ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP5-220/2019E-PDF |
|---|
| 245 | 00|aEvaluation of the Coordination of Antimicrobial Resistance (AMR) activities at the Public Health Agency of Canada / |cprepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
|---|
| 246 | 17|aEvaluation of the Coordination of Antimicrobial Resistance (AMR) activities at PHAC |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cMarch 2019. |
|---|
| 300 | |a1 online resource (x, 33 pages) : |billustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in French under title: Évaluation de la coordination des activités associées à la résistance aux antimicrobiens (RAM) à l'Agence de la santé publique du Canada. |
|---|
| 504 | |aIncludes bibliographical references (pages 30-33). |
|---|
| 520 | |a"This evaluation examined the design, delivery and coordination of the Public Health Agency of Canada's (PHAC) antimicrobial resistance (AMR) activities since 2013-14. This is the first evaluation of PHAC's AMR activities"--Evaluation purpose, page iii. |
|---|
| 610 | 20|aPublic Health Agency of Canada|xEvaluation. |
|---|
| 650 | 0|aAnti-infective agents industry|zCanada|xEvaluation. |
|---|
| 710 | 2 |aPublic Health Agency of Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |bOffice of Audit and Evaluation, |eissuing body. |
|---|
| 775 | 08|tÉvaluation de la coordination des activités associées à la résistance aux antimicrobiens (RAM) à l'Agence de la santé publique du Canada / |w(CaOODSP)9.935321 |
|---|
| 856 | 40|qPDF|s702 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-220-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/report-evaluation-coordination-antimicorbial-resistance-activities.html |
|---|